Clinical trials are under way at two NHS hospitals in England to assess breathalyser technology to detect lung cancer. Phase I clinical trials of a diagnostic breathalyser developed by Cambridge-based Owlstone Ltd have shown accurate identification of 12 lung cancer biomarkers in breath specimens. A Phase II trial is now targeting development of a small, handheld device that can be used in GP…
Patience and persistence are beginning to pay off for University of Montana Professor Mark Grimes, whose research about the behavior of cell proteins in childhood cancer recently was published by the Public Library of Science Computational Biology.
Curetis AG, a developer of next-level molecular diagnostic solutions, announced the successful completion of the clinical and analytical CE performance evaluation of its next-generation Unyvero P55 Pneumonia Application. The upgraded cartridge will launch at the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, April 25 – 28, 2015 in Copenhagen, Denmark) and is…
Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen). The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.
Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The new procedure is six to ten times faster than the one currently used, and equally sensitive. Report: Anja Behringer
Sphere Medical, launches its in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015. The advanced Proxima System delivers true point-of-care testing (POCT) by enabling critical care staff to obtain frequent laboratory accurate blood gas measurements without leaving the patient’s bedside. This facilitates effective and timely clinical decisions…
Iron deficiency and resulting anaemia cause fatal comorbidities worldwide. Despite this, they are generally underestimated. Professor Lothar Thomas, specialist in laboratory medicine at the Central Laboratory in the Frankfurt/Main University Hospital, is seeking more information about new laboratory parameters for diagnosis and monitoring of iron deficiency and iron substitution therapy. The…
A new CE-IVD certified molecular test has been added to Greiner Bio-One’s Genspeed test portfolio for nosocomial infections. In addition to the recently introduced MRSA test, the Genspeed C.diff OneStep test addresses the international need to combat Clostridium difficile (C. diff) infections. The test is analysed on the Genspeed R2 Analyser.
The University Medical Center in Utrecht (UMCU), The Netherlands, is in the process of creating a multidisciplinary centre of excellence, able to manage resources efficiently while delivering the highest level of patient care and clinical research.
For several decades pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in finance and staff.